Predictive value of the serum homocysteine-to-albumin ratio for major adverse cardiovascular events after acute myocardial infarction: a retrospective cohort study
Frontiers in Cardiovascular Medicine · 20.06.2025 · 12
DOI: 10.3389/fcvm.2025.1574139 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 20.06.2025. Verfasst von Jiaping Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Donghai People's Hospital Affiliated to Kangda College of Nanjing Medical University, Lianyungang, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acute myocardial infarction (AMI) remains a major global health burden, with major adverse cardiovascular events (MACE) significantly affecting long-term prognosis. Although the Global Registry of Acute Coronary Events (GRACE) score is widely used for risk stratification, its complexity limits its clinical utility, especially in resource-limited settings. The serum homocysteine-to-albumin ratio (HAR) is a novel biomarker that combines oxidative stress and inflammatory processes, both of which play key roles in cardiovascular pathophysiology. This study aimed to assess the prognostic significance of HAR for MACE in AMI patients.
Methods
A retrospective cohort study was conducted, including 421 AMI patients admitted to Donghai Hospital from January 2022 to December 2023. Clinical and laboratory data, including homocysteine (Hcy), albumin (Alb), and HAR, were collected. The primary outcome was MACE, defined as cardiovascular mortality, non-fatal myocardial infarction, heart failure, recurrent revascularization, stroke, and severe arrhythmias. Multivariable Cox regression analysis was performed to identify independent predictors of MACE. The predictive performance of HAR was assessed using receiver operating characteristic (ROC) curve analysis and compared with Hcy, Alb, and the GRACE score.
Results
During the 12-month follow-up period, 105 patients (24.9%) experienced MACE. The MACE group had significantly higher Hcy levels (15.7 ± 3.4 vs. 12.6 ± 3.1 μmol/L, P < 0.001) and lower Alb levels (34.2 ± 3.9 vs. 38.5 ± 4.2 g/L, P < 0.001). HAR was independently associated with MACE (HR = 1.41, 95% CI: 1.20–1.65, P < 0.001). ROC analysis demonstrated that HAR (AUC = 0.80) outperformed Hcy (AUC = 0.66) and Alb (AUC = 0.73) in predicting MACE, with predictive accuracy comparable to the GRACE score (AUC = 0.82).
Conclusions
HAR is a strong and independent predictor of MACE in AMI patients. Given its simplicity, cost-effectiveness, and availability, HAR may serve as a valuable biomarker for cardiovascular risk stratification, especially in resource-limited settings. Further prospective studies are warranted to validate these findings and explore potential clinical applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Donghai People's Hospital Affiliated to Kangda College of Nanjing Medical University, Lianyungang, China.
- Department of Cardiology, Donghai People's Hospital Affiliated to Kangda College of Nanjing Medical University, Lianyungang, China.
Zitieren
APA
Wang, J., Zhou, J., Wang, N., Fu, M., Song, Z., Hu, M., Wu, H., & Sun, R. (2025). Predictive value of the serum homocysteine-to-albumin ratio for major adverse cardiovascular events after acute myocardial infarction: a retrospective cohort study. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1574139
Vancouver
Wang J, Zhou J, Wang N, Fu M, Song Z, Hu M, et al. Predictive value of the serum homocysteine-to-albumin ratio for major adverse cardiovascular events after acute myocardial infarction: a retrospective cohort study. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1574139
BibTeX
@article{Wang2025,
author = {Wang, Jiaping and Zhou, Jianling and Wang, Na and Fu, Meili and Song, Ziwen and Hu, Ming and Wu, Huiyi and Sun, Runfeng},
title = {Predictive value of the serum homocysteine-to-albumin ratio for major adverse cardiovascular events after acute myocardial infarction: a retrospective cohort study},
journal = {Frontiers in Cardiovascular Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fcvm.2025.1574139}
}
EUVIMED